3nfp: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:3nfp.png|left|200px]] | |||
[[Image:3nfp. | |||
{{STRUCTURE_3nfp| PDB=3nfp | SCENE= }} | {{STRUCTURE_3nfp| PDB=3nfp | SCENE= }} | ||
===Crystal structure of the Fab fragment of therapeutic antibody daclizumab in complex with IL-2Ra (CD25) ectodomain=== | ===Crystal structure of the Fab fragment of therapeutic antibody daclizumab in complex with IL-2Ra (CD25) ectodomain=== | ||
{{ABSTRACT_PUBMED_20820193}} | {{ABSTRACT_PUBMED_20820193}} | ||
==About this Structure== | ==About this Structure== | ||
[[3nfp]] is a 6 chain structure of [[Interleukin receptor]] and [[Monoclonal Antibody]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3NFP OCA]. | |||
==See Also== | |||
*[[Interleukin receptor|Interleukin receptor]] | |||
*[[Monoclonal Antibody|Monoclonal Antibody]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:020820193</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Ding, J.]] | [[Category: Ding, J.]] | ||
Line 38: | Line 30: | ||
[[Category: Therapeutic antibody]] | [[Category: Therapeutic antibody]] | ||
[[Category: Zenapax]] | [[Category: Zenapax]] | ||
Revision as of 05:05, 26 July 2012
Crystal structure of the Fab fragment of therapeutic antibody daclizumab in complex with IL-2Ra (CD25) ectodomainCrystal structure of the Fab fragment of therapeutic antibody daclizumab in complex with IL-2Ra (CD25) ectodomain
Template:ABSTRACT PUBMED 20820193
About this StructureAbout this Structure
3nfp is a 6 chain structure of Interleukin receptor and Monoclonal Antibody with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See AlsoSee Also
ReferenceReference
- ↑ Yang H, Wang J, Du J, Zhong C, Zhang D, Guo H, Guo Y, Ding J. Structural basis of immunosuppression by the therapeutic antibody daclizumab. Cell Res. 2010 Sep 7. PMID:20820193 doi:10.1038/cr.2010.130